Tasimelteon CAS No. 609799-22-6

Luhan Pharmachem Co., Ltd. supplies Tasimelteon bulk active pharmaceutical ingredient (API) to the pharmaceutical industry. Our Tasimelteon is manufactured by cGMP compliant facility. Welcome to contact us for further details including current DMF status for the product and up to date regulatory status of the manufacturing facility. We look forward to assisting you with your research and development projects.   What is Tasimelteon? Tasimelteon (trade name Hetlioz) is a drug approved by the FDA solely for the treatment of non-24-hour sleep–wake disorder (often designated as N24HSWD). It is a selective agonist for the melatonin receptors MT1 and MT2 in the suprachiasmatic nucleus of the brain, malady similar to other members of the melatonin receptor agonist class of which Ramelteon (2005) and agomelatine (2009) were the first approved. In June 2014, the European Medicines Agency accepted an EU filing application for tasimelteon. As a treatment for N24HSWD, check as with melatonin or ot…